Literature DB >> 25415415

Is it possible to sanitize athletes' shoes?

Gabriele Messina1, Sandra Burgassi, Carmela Russo, Emma Ceriale, Cecilia Quercioli, Cosetta Meniconi.   

Abstract

CONTEXT: Footwear should be designed to avoid trauma and injury to the skin of the feet that can favor bacterial and fungal infections. Procedures and substances for sanitizing the interior of shoes are uncommon but are important aspects of primary prevention against foot infections and unpleasant odor.
OBJECTIVE: To evaluate the efficacy of a sanitizing technique for reducing bacterial and fungal contamination of footwear.
DESIGN: Crossover study.
SETTING: Mens Sana basketball team. PATIENTS OR OTHER PARTICIPANTS: Twenty-seven male athletes and 4 coaches (62 shoes). INTERVENTION(S): The experimental protocol required a first sample (swab), 1/shoe, at time 0 from inside the shoes of all athletes before the sanitizing technique began and a second sample at time 1, after about 4 weeks, April 2012 to May 2012, of daily use of the sanitizing technique. MAIN OUTCOME MEASURE(S): The differences before and after use of the sanitizing technique for total bacterial count at 36 °C and 22 °C for Staphylococcus spp, yeasts, molds, Enterococcus spp, Pseudomonas spp, Escherichia coli , and total coliform bacteria were evaluated.
RESULTS: Before use of the sanitizing technique, the total bacterial counts at 36 °C and 22 °C and for Staphylococcus spp were greater by a factor of 5.8 (95% confidence interval [CI] = 3.42, 9.84), 5.84 (95% CI = 3.45, 9.78), and 4.78 (95% CI = 2.84, 8.03), respectively. All the other comparisons showed a reduction in microbial loads, whereas E coli and coliforms were no longer detected. No statistically significant decrease in yeasts (P = .0841) or molds (P = .6913) was recorded probably because of low contamination.
CONCLUSIONS: The sanitizing technique significantly reduced the bacterial presence in athletes' shoes.

Entities:  

Keywords:  athlete's foot; bacterial infections; basketball; foot infections; fungal infections; hygiene

Mesh:

Substances:

Year:  2014        PMID: 25415415      PMCID: PMC4495438          DOI: 10.4085/1062-6050-49.3.55

Source DB:  PubMed          Journal:  J Athl Train        ISSN: 1062-6050            Impact factor:   2.860


  26 in total

1.  Incidence of occult athlete's foot in swimmers.

Authors:  A Attye; P Auger; J Joly
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

2.  Fungal infection of the feet in soccer players and non-athlete individuals.

Authors:  Kátia Sheylla Malta Purim; Gisele Pesquero Fernandes Bordignon; Flávio de Queiroz-Telles
Journal:  Rev Iberoam Micol       Date:  2005-03       Impact factor: 1.044

3.  [Where does the shoe hurt? Most women wear too small and too narrow shoes].

Authors:  H R Meyer
Journal:  Z Orthop Ihre Grenzgeb       Date:  1996 Mar-Apr

4.  Epidemiological and aetiological study on tinea pedis and onychomycosis in Algeria.

Authors:  Assya Djeridane; Yasmina Djeridane; Aomar Ammar-Khodja
Journal:  Mycoses       Date:  2006-05       Impact factor: 4.377

Review 5.  Tinea pedis.

Authors:  J J Leyden; R Aly
Journal:  Semin Dermatol       Date:  1993-12

6.  [Foot mycosis in sportsmen].

Authors:  A B Macura; B Wnuk
Journal:  Przegl Dermatol       Date:  1982 May-Jun

7.  Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain.

Authors:  S Perea; M J Ramos; M Garau; A Gonzalez; A R Noriega; A del Palacio
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  Dermatophyte feet infection among students enrolled in swimming courses at a university pool.

Authors:  B Bolaños
Journal:  Bol Asoc Med P R       Date:  1991-05

9.  Cefsulodin therapy for osteomyelitis due to Pseudomonas aeruginosa.

Authors:  J C Pottage; P H Karakusis; G M Trenholme
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

10.  Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus.

Authors:  R A Proctor; P van Langevelde; M Kristjansson; J N Maslow; R D Arbeit
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.